UiPath Announces Passing of Director and Board Nominee, Reduces Board Size
PATH sits 19% above its 52-week low of $9.2.
Summary
UiPath announced the passing of director Sivaramakichenane Somasegar, a nominee for re-election, leading the board to reduce its size and adjust the upcoming annual meeting's director election.
Key Events · Executive and Board Changes · PATH
-
Director's Passing Announced
Sivaramakichenane Somasegar, a director since September 2024 and a nominee for re-election at the June 25, 2026 Annual Meeting, passed away on May 19, 2026.
-
Board Size Reduced
The Board of Directors has reduced its size to eliminate the vacancy created by Mr. Somasegar's death. Only the remaining seven nominees will stand for election at the Annual Meeting.
-
Committee Appointment
June Yang has been appointed to serve on the Nominating and Corporate Governance Committee of the Board.
-
Proxy Statement Update
This filing serves as additional materials for the proxy statement filed on May 12, 2026, informing shareholders that votes cast for Mr. Somasegar will not be counted.
Analysis · PATH · Technology
This filing updates the proxy statement for the upcoming annual meeting, informing shareholders of the passing of director Sivaramakichenane Somasegar, who was also a nominee for re-election. The board has responded by reducing its size to eliminate the vacancy, ensuring the election proceeds with the remaining seven nominees. This event impacts corporate governance and board composition.
At the time of this filing, PATH was trading at $10.91 on NYSE in the Technology sector, with a market capitalization of approximately $5.7B. The 52-week trading range was $9.20 to $19.84. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.